These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 16035049)
1. A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy. Price CS; Taylor FB Depress Anxiety; 2005; 21(4):149-53. PubMed ID: 16035049 [TBL] [Abstract][Full Text] [Related]
2. A prospective trial of modafinil as an adjunctive treatment of major depression. DeBattista C; Lembke A; Solvason HB; Ghebremichael R; Poirier J J Clin Psychopharmacol; 2004 Feb; 24(1):87-90. PubMed ID: 14709953 [TBL] [Abstract][Full Text] [Related]
3. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study. Lundt L J Affect Disord; 2004 Aug; 81(2):173-8. PubMed ID: 15306145 [TBL] [Abstract][Full Text] [Related]
4. Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice. Nasr S; Wendt B; Steiner K J Affect Disord; 2006 Oct; 95(1-3):111-4. PubMed ID: 16737742 [TBL] [Abstract][Full Text] [Related]
5. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016 [TBL] [Abstract][Full Text] [Related]
6. Modafinil therapy for apathy in an elderly patient. Padala PR; Burke WJ; Bhatia SC Ann Pharmacother; 2007 Feb; 41(2):346-9. PubMed ID: 17264158 [TBL] [Abstract][Full Text] [Related]
7. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. Vaishnavi S; Gadde K; Alamy S; Zhang W; Connor K; Davidson JR J Clin Psychopharmacol; 2006 Aug; 26(4):373-8. PubMed ID: 16855454 [TBL] [Abstract][Full Text] [Related]
8. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Rasmussen NA; Schrøder P; Olsen LR; Brødsgaard M; Undén M; Bech P Nord J Psychiatry; 2005; 59(3):173-8. PubMed ID: 16208839 [TBL] [Abstract][Full Text] [Related]
9. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628 [TBL] [Abstract][Full Text] [Related]
10. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Rabkin JG; Gordon PH; McElhiney M; Rabkin R; Chew S; Mitsumoto H Muscle Nerve; 2009 Mar; 39(3):297-303. PubMed ID: 19208404 [TBL] [Abstract][Full Text] [Related]
11. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Lam JY; Freeman MK; Cates ME Ann Pharmacother; 2007 Jun; 41(6):1005-12. PubMed ID: 17519297 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134 [TBL] [Abstract][Full Text] [Related]
13. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135 [TBL] [Abstract][Full Text] [Related]
14. The effect of modafinil on self-esteem in spinal cord injury patients: a report of 2 cases and review of the literature. Mukai A; Costa JL Arch Phys Med Rehabil; 2005 Sep; 86(9):1887-9. PubMed ID: 16181960 [TBL] [Abstract][Full Text] [Related]
15. Adjunctive atomoxetine for residual fatigue in major depressive disorder. Papakostas GI; Petersen TJ; Burns AM; Fava M J Psychiatr Res; 2006 Jun; 40(4):370-3. PubMed ID: 15978621 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825 [TBL] [Abstract][Full Text] [Related]
17. Modafinil as an adjunctive treatment to sleep deprivation in depression. Even C; Thuile J; Santos J; Bourgin P J Psychiatry Neurosci; 2005 Nov; 30(6):432-3. PubMed ID: 16327878 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, crossover trial of modafinil on mood. Taneja I; Haman K; Shelton RC; Robertson D J Clin Psychopharmacol; 2007 Feb; 27(1):76-9. PubMed ID: 17224718 [TBL] [Abstract][Full Text] [Related]
19. Modafinil as adjunctive therapy in depressed outpatients. Nasr S Ann Clin Psychiatry; 2004; 16(3):133-8. PubMed ID: 15517845 [TBL] [Abstract][Full Text] [Related]
20. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. Biederman J; Pliszka SR J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]